Saphenous vein graft failure: from pathophysiology to prevention and treatment strategies
I Xenogiannis, M Zenati, DL Bhatt, SV Rao… - Circulation, 2021 - Am Heart Assoc
Saphenous vein grafts (SVGs) remain the most frequently used conduits in coronary artery
bypass graft surgery (CABG). Despite advances in surgical techniques and …
bypass graft surgery (CABG). Despite advances in surgical techniques and …
Association of dual antiplatelet therapy with ticagrelor with vein graft failure after coronary artery bypass graft surgery: a systematic review and meta-analysis
S Sandner, B Redfors, DJ Angiolillo, K Audisio… - Jama, 2022 - jamanetwork.com
Importance The role of ticagrelor with or without aspirin after coronary artery bypass graft
surgery remains unclear. Objective To compare the risks of vein graft failure and bleeding …
surgery remains unclear. Objective To compare the risks of vein graft failure and bleeding …
Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
Multiple guidelines and consensus papers have addressed the role of antithrombotic
strategies in patients with established coronary artery disease (CAD). Since evidence and …
strategies in patients with established coronary artery disease (CAD). Since evidence and …
Graft failure after coronary artery bypass grafting and its association with patient characteristics and clinical events: a pooled individual patient data analysis of clinical …
BACKGROUND: Graft patency is the postulated mechanism for the benefits of coronary
artery bypass grafting (CABG). However, systematic graft imaging assessment after CABG is …
artery bypass grafting (CABG). However, systematic graft imaging assessment after CABG is …
Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial
Objective To assess the effect of different antiplatelet strategies on clinical outcomes after
coronary artery bypass grafting. Design Five year follow-up of randomised Different …
coronary artery bypass grafting. Design Five year follow-up of randomised Different …
Ticagrelor versus aspirin and vein graft patency after coronary bypass: a randomized trial
A Kulik, AM Abreu, V Boronat… - Journal of Cardiac …, 2022 - Wiley Online Library
Background Antiplatelet therapy prevents saphenous vein graft (SVG) occlusion and
improves outcomes after coronary artery bypass graft surgery (CABG). However, the optimal …
improves outcomes after coronary artery bypass graft surgery (CABG). However, the optimal …
Antithrombotic therapy in patients with established atherosclerotic coronary disease
A Landi, M Valgimigli - Heart, 2023 - heart.bmj.com
Antithrombotic therapy is the cornerstone of the pharmacological treatment in patients with
established coronary artery disease (CAD). 1 Despite technological improvements, the …
established coronary artery disease (CAD). 1 Despite technological improvements, the …
[HTML][HTML] Angiographic outcomes for arterial and venous conduits used in CABG
A Dimagli, G Soletti Jr, L Harik… - Journal of Clinical …, 2023 - mdpi.com
Coronary artery bypass grafting is the most commonly performed cardiac surgical
procedure. Conduit selection is crucial to achieving early optimal outcomes, with graft …
procedure. Conduit selection is crucial to achieving early optimal outcomes, with graft …
Conduit selection and early graft failure in coronary artery bypass surgery: a post hoc analysis of the Cardiovascular Outcomes for People Using Anticoagulation …
M Alboom, A Browne, T Sheth, Z Zheng… - The Journal of Thoracic …, 2023 - Elsevier
Objectives Relative rates of early graft failure and conduit selection in coronary artery
bypass grafting (CABG) surgery remain controversial. Therefore, we sought to determine the …
bypass grafting (CABG) surgery remain controversial. Therefore, we sought to determine the …
[HTML][HTML] A Contemporary Review of Antiplatelet Therapies in Current Clinical Practice
S Arockiam, B Staniforth, S Kepreotis… - International Journal of …, 2023 - mdpi.com
Antiplatelet therapy plays a crucial role in a number of cardiovascular disorders. We
currently have a range of antiplatelet agents in our armamentarium. In this review, we aim to …
currently have a range of antiplatelet agents in our armamentarium. In this review, we aim to …